Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractBreath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study    Next AbstractExhaled breath analysis in hepatology: State-of-the-art and perspectives »

Liver Int


Title:Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients
Author(s):De Vincentis A; Pennazza G; Santonico M; Vespasiani-Gentilucci U; Galati G; Gallo P; Zompanti A; Pedone C; Antonelli Inc; Picardi A;
Address:"Clinical Medicine and Hepatology Department, Campus Bio-Medico University, Rome, Italy. Center for Integrated Research - CIR, Unit of Electronics for Sensor Systems, Campus Bio-Medico University, Rome, Italy. Chair of Geriatrics, Unit of Respiratory Pathophysiology, Campus Bio-Medico University, Rome, Italy. San Raffaele- Cittadella della Carita Foundation, Taranto, Italy"
Journal Title:Liver Int
Year:2017
Volume:20160821
Issue:2
Page Number:242 - 250
DOI: 10.1111/liv.13214
ISSN/ISBN:1478-3231 (Electronic) 1478-3223 (Linking)
Abstract:"BACKGROUND & AIMS: The spectrum of volatile organic compounds in the exhaled breath (breath-print, BP) has been shown to characterize patients with cirrhosis and with worse hepatic function. However, the association of different BPs with clinically relevant outcomes has not been described yet. Hence, we aimed to evaluate the association between BPs, mortality and hospitalization in cirrhotic patients and to compare it with that of the 'classical' prognostic indices (Child-Pugh Classification [CPC] and MELD). METHODS: Eighty-nine cirrhotic patients (M/F 59/30, mean age 64.8 +/- 11.3, CPC A/B/C 37/33/19) were recruited and followed up for a median time of 23 months. Clinical and biochemical data were collected. Breath collection and analysis were obtained through Pneumopipe((R)) and BIONOTE e-nose respectively. RESULTS: Four different BP clusters (A, B, C, D) were identified. BP clusters A and D were associated with a significantly increased risk of mortality (HR 2.9, 95% confidence intervals [CI] 1.5-5.6) and hospitalization (HR 2.6, 95% CI 1.4-4.6), even in multiple adjusted models including CPC and MELD score (adjusted [a]HR 2.8, 95% CI 1.1-7.0 for mortality and aHR 2.2, 95% CI 1.1-4.2 for hospitalization). CPC C maintained the strongest association with both mortality (aHR 17.6, 95% CI 1.8-174.0) and hospitalization (aHR 12.4, 95% CI 2.0-75.8). CONCLUSIONS: This pilot study demonstrates that BP clusters are associated with significant clinical endpoints (mortality and hospitalization) even independently from 'classical' prognostic indices. Even though further studies are warranted on this topic, our findings suggest that the e-nose may become an adjunctive aid to stratify the risk of adverse outcomes in cirrhotic patients"
Keywords:Aged Breath Tests/*instrumentation *Electronic Nose Female Hospitalization Humans Liver Cirrhosis/*diagnosis Liver Function Tests/*instrumentation Male Middle Aged Pilot Projects Risk Assessment Severity of Illness Index Survival Analysis Time Factors Vol;
Notes:"MedlineDe Vincentis, Antonio Pennazza, Giorgio Santonico, Marco Vespasiani-Gentilucci, Umberto Galati, Giovanni Gallo, Paolo Zompanti, Alessandro Pedone, Claudio Antonelli Incalzi, Raffaele Picardi, Antonio eng 2016/08/09 Liver Int. 2017 Feb; 37(2):242-250. doi: 10.1111/liv.13214. Epub 2016 Aug 21"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 29-06-2024